Bortezomib 00409-1703

Product NDC

00409-1703

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: May 16, 2022
Listing Expires: December 31, 2026
Application: NDA209191

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	2.5 mg/1

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Packaging Options(1)

00409-1703-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1703-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

View →